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Actions of cyclosporin A on cultured rat mesangial cells. The effects of
cyclosporin A (CsA) on planar surface area of cultured rat mesangial
cells (PCSA) and cross-sectional area of isolated rat giomeruli (GCSA)
were tested. The same experiments were performed after preincubation
with platelet activating factor (PAF) antagonists (BN 52021, alprazo-
lam) or calcium channel blockers (verapamil). Areas of cells or glomer-
uli were analyzed by a computer-assisted method. CsA reduced PCSA
in a time-dependent (significant effects began at 15 mm, about 12% of
reduction with 10-6 M CsA) and dose-dependent (no effect at iO M
CsA, maximal reduction of about 30% at 60 mm of incubation with 10
M CsA) fashion. BN 52021 (5.10-s M) and alprazolam (10 M) com-
pletely inhibited the reduction of mesangial cell area induced by CsA.
Verapamil (l0 M) only partially inhibited this action. Glomerular
cross-sectional area decreased after 30 minutes of incubation with 10 6
M CsA (1,45 0.02 vs. 1.55 0.02 rn2 10_8, P< 0.001), an effect that
was inhibited by BN 52021 or verapamil. In addition, lO_6 M CsA
increased PAF production by isolated rat glomeruli (425 80 pg/mg vs.
198 13 pg/mg in control glomeruli, P < 0.01), an effect which was not
inhibited by verapamil. These results suggest that CsA could reduce
GFR by decreasing the glomerular ultrafiltration coefficient, perhaps as
a consequence of the contraction of mesangial cells. PAF seems to play
a pivotal role in the genesis of this action.
Cyclosporin A (CsA) probably represents the most important
therapeutic advance which has taken place in recent years in
the field of kidney transplantation [1]. However, its nephrotox-
icity remains a relevant clinical problem [2]. Among the wide
spectrum of renal alterations induced by CsA, the production of
transient acute renal failure has received special attention [3].
The mechanisms underlying this disorder are not completely
known. Acute intravenous injection to rats of doses of CsA
similar to those used in human transplantation induces a pro-
gressive increase in renal vascular resistances (RVR) accompa-
nied by a parallel reduction in renal blood flow (RBF) and
glomerular filtration rate (GFR) [4]. The renin-angiotensin sys-
tem [5], the autonomous nervous system [61, and some prosta-
noids [5,71 have been implied in the genesis of these alterations.
Recently, Barros et al [8] have shown that CsA is able to
directly modify the glomerular ultrafiltration coefficient (Kf)
independently of the changes in RBF, suggesting another phy-
siopathological alternative to the CsA-induced reduction of the
GFR.
Several local mediators probably play an important role in the
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regulation of RVR or K [9]. Platelet activating factor (PAF)
seems to be one of them, it being able to reduce RBF and GFR
[10]. Recent results have shown that isolated glomeruli [11] or
cultured rat mesangial cells [12, 13] contract in presence of
PAF. In addition, Schlondorif and colleagues have demon-
strated that under certain conditions cultured mesangial cells
are able to synthesize PAF [14].
In this work, we analyzed the effects of CsA on the contrac-
tion of cultured rat mesangial cells and isolated glomeruli. As
these effects have been related to changes in the Kf [15, 16],
with these experiments we tried to clarify some of the mecha-
nisms responsible for the acute reduction of GFR induced by
CsA. Moreover, we attempted to assess a possible role of PAF
as a mediator of the observed effects of CsA.
Methods
Materials
Collagenase type IA, from Clostridium histolyticum and
L-glutamine were purchased from Sigma Chemical Company
(St. Louis, Missouri, USA). Penicillin was obtained from Lab-
oratories Level SA (Barcelona, Spain). Streptomycin sulfate
was obtained from Antibioticos SA (Madrid, Spain). Hank's
balanced salt solution and total calf serum were obtained from
Flow Laboratories (Woodcock Hill, UK). Cyclosporin A was
by Sandoz (Basel, Switzerland). BN 52021 was from Henri
Beaufour Institute (Paris, France). Verapamil was from Knoll
(Madrid, Spain) and alprazolam was purchased from Upjohn
(Kalamazoo, Michigan, USA). PAF was purchased from Ba-
chem (Bubendorf, Switzerland) and PH]-Serotonin (5-Hy-
droxy[G-3H1-tryptamine creatinine sulphate) and [3H]-throm-
boxane B2 from Amersham (Buckinghamshire, UK). [1251]_
cyclosporine was obtained from Incstar (Stillwater, Minnesota,
USA).
Glomerular isolation and mesangia! cell culture
Renal glomeruli were isolated from Wistar rats weighing 150
to 200 g and maintained on standard rat chow with free access
to tap water. Kidneys were removed under ether anesthesia and
glomeruli isolated by successive mechanical sieving (105 and 75
m) as previously described [171. The flulal preparation con-
sisted of glorneruli without Bowman's capsule and afferent or
efferent arterioles, with a tubular contamination of less than
5%. Buffer A (Tris 20 msi, NaCI 130 mM, KCI 10 m, sodium
acetate 10 m, glucose 5 mt't, pH 7.45) was used in all the steps
of the isolation procedures.
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Isolated glomeruli obtained by a similar mechanical sieving
procedure (150 and 50 m) from rats weighing 100 to 150 g were
treated with collagenase, plated in plastic culture flasks and
incubated as previously described [18]. The culture medium
consisted of RPMI 1640 supplemented with 10% fetal calf
serum, L-glutamine (1 mM), penicillin (60 iJml), streptomycin
sulfate (60 .tg/ml), and buffered with Hepes, pH 7.2. Culture
media were changed every two days. Epithelial cells grew
rapidly whereas mesangial cells grew slowly, with a peak of
mesangial cell density between 18 and 22 days. Studies were
performed on this interval when epithelial cells were no longer
detected in the culture flasks. Identification of the cells was
performed by morphological, immunological and functional
criteria [19]. Under phase contrast microscopy, all the cells
appeared large and stellate. By transmission electron micros-
copy, the examined cells contained numerous bundles of mi-
crofilaments, high density patches and elongated nuclei. Mesan-
gial cells showed evidences of containing myosin fibers and
they did not stain for von Willebrand factor. In addition, the
cultures did not show activity of angiotensin converting en-
zyme. No cells with epithelial or endothelial morphological
characteristics were detected in the cultures.
Incubation procedure
In every experiment, cells or glomeruli were washed twice,
discarding the culture or isolation media and placed in fresh
buffer A containing 2.5 mrvi Cat After 15 minutes at room
temperature, experiments were started.
In a first set of experiments, cultured mesangial cells were
incubated at several times (8, 15, 30, 60 mm) with a fixed
concentration of CsA (10—6 M final concentration). The mesan-
gial cells were incubated for 30 minutes with variable doses of
CsA (10_6 to l0 M final concentrations). In a second set of
experiments, cells were incubated with BN 52021 (BN) (5. l0
M final concentration) or alprazolam (ALP; l0— M final con-
centration). After 10 minutes, CsA (10_6 M) was added to the
incubation media (time 0), performing incubations at variable
times (8, 15, 30, 60 mm). In a similar fashion, preincubation
with verapamil (VP) (1O M final concentration) was made. In
order to discard a non-specific effect of BN, angiotensin II (l0
M) was added to mesangial cells preincubated for 10 minutes
with BN (5. l0- M final concentration), performing incubations
for 45 minutes. Controls were introduced in each group with the
same final concentration of the vehicles used to solve the
reactives (ALP and VP were solved in buffer A. CsA and BN
were solved in ethanol, with a final concentration of 0.1%).
Moreover, the intrinsic effects of BN, ALP and VP at the same
concentrations cited above were tested. The ability of mesan-
gial cells incubated for 60 minutes with CsA 106 M to exclude
the trypan blue dye was also tested.
Isolated glomeruli were incubated for 30 minutes at room
temperature with CsA (10_6 M final concentration), and com-
pared with glomeruli treated in the same way but preincubated
for 10 minutes with BN (5.10 M final concentration) or VP
(10 M final concentration). As in the case of the cells, controls
were performed with the solvent and with BN or VP alone.
Determination of planar cell-surface area (PCSA) and
glomerular cross-sectional area (GCSA)
While incubations were performed, mesangial cells grown in
conventional plastic culture flasks or samples of 100 d of
glomerular suspensions on excavated glass slides, maintained at
room temperature (22 2°C), were observed under phase
contrast with inverted Olympus photomicroscope (Olympus
IMT2, Shibuya-Hu, Tokyo, Japan) with a 150 magnification [11,
20]. Serial photographs were taken under the experimental
conditions cited above. Fifteen to 27 cells and 30 to 50 glomeruli
were analyzed per photograph. PCSA and GCSA were deter-
mined by computer-aided planimetric techniques (Cardio-80,
Kontron Medical, FRG). Actual areas were calculated after
correction for microscope and photographic magnifications.
Measurements were performed by two investigators in a blind
fashion.
Production of PAF by isolated rat gloineruli
Freshly isolated glomeruli were incubated at room tempera-
ture for 30 minutes in tubes containing 1.5 ml of buffer A with
phenylmethylsulfonyl fluoride (PMSF, lO M final concentra-
tion), to prevent rapid degradation of PAF. CsA at 106 M or
ethanol (0.2% final concentration), the solvent of CsA, were
added to the incubation media. Afterwards, similar incubations
were performed but in the presence of l0— M VP. A blank
containing 106 M CsA but no glomeruli was also introduced.
Protein quantitation in aliquots from the glomerular suspension
was performed according to Lowry et al [21]. Glomeruli were
separated for centrifugation at 3000 rpm for three minutes at
4°C. Supernatants were mixed with 5 ml of cold methanol
acidified with acetic acid (49:1, vol:vol), and PAF was ex-
tracted as described below. Glomeruli were mixed with 5 ml of
cold acidified methanol, sonicated for 30 seconds, and slowly
stirred for 30 minutes at 4°C. The tubes were centrifuged and
the pellet was again mixed with 5 ml of cold ethanol, stirred for
30 minutes and centrifugated. Both methanolic phases were
pooled. PAF was extracted from the methanolic phase as
previously described [22]. In brief, chloroform and water were
added to the methanol to a proportion of 1:0.9:1 vol:vol
(chloroform: water: methanol) and gently stirred. After phase
formation by centrifugation, chloroform phase was removed
and new chloroform added to the methanol: water in the same
proportion as reported above. The process was repeated and
both chloroform extracts were pooled and dried under N2
atmosphere. PAF extraction was performed with silica car-
tridges (Sep-Pak, Waters, Milford, Massachusetts, USA). Car-
tridges were rinsed with 5 ml of chloroform, and then the
sample resuspended in 5 ml of chloroform acidified with HCI to
pH 3 to 4 was applied to the cartridge. The column was eluted
sequentially with 5 ml of chloroform-methanol (3:2), 5 ml of
chloroform-methanol (1:3) and 5 ml of methanol-water (3: 1).
The last fraction containing PAF was collected and dried under
nitrogen atmosphere. The recovery of PAP in the whole extrac-
tion procedure varied between 70 and 80%. When '251-cyclo-
sporine or 3H-thromboxane B2 was added to the incubation
media, no radioactivity was recovered in this fraction. Bioas-
sayable PAF activity was determined by the release of 3H-
serotonin from preloaded rabbit platelets as previously de-
scribed [22]. A standard curve of response to PAP was made
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Fig. 1. Effect of cyclosporin A on the planar cell surface area (PCSA)
of cultured rat mesangial cells. Results are expressed as percent (%) of
the initial PCSA (100%) and each point represents the mean of 5
experiments (25—50 cells measured in each experiment). C, control
cells; CsA, cells incubated with 10651 CsA. *f < 0.05 vs. C. 1:P <
0.05 vs. time 0. 2:? < 0.05 vs. time 8. 3: P < 0.05 vs. time 15. 4:P <
0.05 vs. time 30.
with concentrations between 0.01 nglml and I nglml. The
amount of 3H-serotonin released for the lower standard con-
centration was significantly higher than the nonspecific release.
Only the values corresponding to the linear portion of the curve
(between 0.01 ng/mI and 0.2 ng/ml) were used for quantitation.
Intra-assay variation was about 6.4% and PAF interassay
variation was about 17%. PAF production was considered the
result of PAF in supernatants plus PAF in glomeruli.
Statistical methods
Results are expressed as X SEM. In the studies with cells,
comparison were performed by the paired Student's t-test,
two-way analysis of variance and Scheffe's multiple compari-
son test. For the glomeruli, the unpaired Student's t-test,
one-way analysis of variance and Scheffe's multiple comparison
test were used. Differences in the glomerular PAF production
were analyzed by the Kruskal-Wallis and Mann-Whitney tests.
Results
PCSA decreased when mesangial cells were incubated in the
presence of l06 M CsA (Fig. 1). This effect appeared after 15
minutes of incubation, increasing progressively as a function of
the time (Fig. 1). Moreover, it seems that the CsA-induced
reduction of PCSA was a dose-dependent phenomenon, being
detectable over a concentration of CsA of iO M and reaching
a maximum at i0 M (Fig. 2). No changes could be observed in
PCSA of control mesangial cells incubated with ethanol through
the whole experimental period. Considering a 10% of reduction
in PCSA as a significant contraction, I0_6 M CsA contracted an
average of 76% of cells after 60 minutes of incubation, whereas
only 11% of control cells contracted under the same experimen-
tal conditions. More than 95% of the cells incubated with 10—6
M CsA excluded the trypan blue dye after 60 minutes.
C 9 8 7 6
- LOG ICsAI, M
Fig. 2. Effect of variable doses of cyclosporin A on the planar cell
surface area (PCSA) of cultured rat mesangial cells at 30 mm of
incubation. Results are expressed as percent (%) of the initial PCSA
(100%) and each point represents the mean of 5 experiments (25—50 cells
measured in each experiment). C: Control cells. l:P <0.05 vs. C and
9. 2:P < 0.05 vs. 8.
Time, rn/n
Fig. 3. Effects of the pro-incubation with BN 52021 or alprazolam on
the action of cyclosporin A on planar cell surface area (PCSA) of
cultured rat mesangial cells. Results are expressed as percent (%) of the
initial PCSA (100%) and each point represents the mean of 5 experi-
ments (25—50 cells measured in each experiment). C: Control cells.
CsA: 106 M cyclosporin A. BN + CsA: 5.l0 M BN 52021 pIus 106
M cyclosporin A, ALP + CsA: 10 M aiprazolam plus 10-6 51
cyclosporin A. P < 0.05 versus C, BN + CsA and ALP + CsA.
Preincubation of mesangial cells with BN or ALP completely
blunted the contractile response to CsA. In both cases, PCSA
did not show consistent variations for 60 minutes with respect
to the initial surface, behaving as control cells (Fig. 3). In
contrast, when l0— M angiotensin II was added to mesangial
cells preincubated for 10 minutes with BN, a significant reduc-
tion of PCSA was observed after 45 minutes of incubation (68
4% of the initial PCSA; N 3). VP was also able to partially
inhibit the CsA-induced reduction of PCSA, but a significant
C
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Fig. 4. Effects of the pre-incubation with verapamil on the action of
cyclosporin A on planar cell surface area (PCSA) of cultured rat
mesangial cells. Results are expressed as percent (%) of the initial
PCSA (100%) and each point represents the mean of 5 experiments (25—
50 cells measured in each experiment). C: control cells. CsA: 106 M
cyclosporin A. VP: io— M verapamil plus 10-6 55 CsA. < 0.05 vs.
C.
Time mm
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reduction of PCSA was still observed after 60 minutes of
incubation (Fig. 4). Neither BN or ALP nor VP modified PCSA
when used without CsA (Table 1).
Figure 5 shows the effects of CsA on isolated rat glomeruli.
The GCSA at time 0 did not differ among the four experimental
groups. However, after 30 minutes of incubation, the mean
GCSA of CsA-treated glomeruli decreased significantly with
respect to the basal values, whereas no changes could be
detected in control glomeruli. Preincubation with BN or VP
totally inhibited the reduction of GCSA induced by CsA.
Table 1 shows the glomerular production of PAF with (CsA)
or without (Control) cyclosporine in presence or absence of VP.
CsA induced a significant increase in the amount of PAF
synthesized by isolated glomeruli, an effect which was not
inhibited by VP. VP alone did not modify the glomerular
production of PAF.
Discussion
The present results demonstrate the ability of CsA to reduce
planar surface area of rat mesangial cells in primary culture.
This effect is time dependent, appearing after 15 minutes of
incubation at room temperature with 10—6 M CsA, and increas-
ing progressively. Moreover, a dose-dependent response was
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FIg. 5. Effect of 10-6 M cyclosporin A on isolated rat glomeruli
pre-incubated with 5.10-i M BN 52021 (RN + CsA) or io M (VP +
CsA) verapamil. Each bar represents the mean of 3 experiments and
numbers within the bars are the average number of glomeruli analyzed
in each experiment). p < 0.05 vs. time 0 and vs. C, BN + CsA and VP
+ GsA at time 30.
Control CsA
Without VP 198 13 425 80
N = 12
With VP 224 56 401 6l
N= 6
observed, with no action of CsA at i0 M and a maximal
reduction of mesangial planar surface at l0 M. It does not
seem probable that the observed effects could be explained by
a nonspecific toxic action of CsA on cultured mesangial cells as
no detachment of the cells were observed in any case and cells
were able to exclude the trypan blue dye after the incubations
were performed.
The mechanisms responsible for this reduction of planar
surface have been partially studied in the present work. When
the effect of CsA was tested in presence of two well-known
inhibitors of the interaction of PAF with its receptors, BN 52021
and alprazolam [231, the effect on the planar surface area of
mesangial cells was completely abolished. This blockade does
not seem to be a nonspecific action of the BN, as this substance
was unable to inhibit the cellular contraction induced by angio-
tensin II. These results suggest that the production of PAF is an
intermediate step in the induction of the observed effects of
CsA on cultured mesangial cells. In addition, the use of the
calcium channel blocker VP [24] partially prevented the reduc-
tion of mesangial planar surface area induced by CsA, suggest-
ing that entry of calcium to the cell could play some role in the
observed effects of CsA on mesangial cells. These results
strongly suggest that the incubation of cultured rat mesangial
100
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4U)0
I
125
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130
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Table 1. Time course studies of PCSA from cells incubated with BN
52021 (BN: 5.l05 M) aiprazolam (ALP: 10 M) and verapamil
(VP:105 M) alone, in comparison with control (C) cells
Table 2. Production of PAF (pg/mg of glomerular protein) by isolated
rat glomeruli
a PCSA is expressed as percent of initial values. Data are X SEM.
Abbreviations are: CsA, 10—6 M cyclosponn A; VP, l0 M vera-
pamil. Values are X SEM.
a P < 0.05 vs. control.
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cells with CsA stimulates the synthesis of PAF. PAF, acting on
the cultured cells, could modify the cytosolic free calcium
concentrations, thus determining a cell contraction. Previous
experimental results support these hypotheses: 1.) Cultured rat
mesangial cells are able to synthesize PAF, at least under
adequate stimulus [141. 2.) Planar surface of cultured mesangial
cells is reduced by PAF [12, 13, 25]. 3.) PAF increases the
intracytosolic concentration of free calcium [26, 27]. 4.) Cal-
cium channel blockers can inhibit the actions of PAF on planar
surface of mesangial cells [25]. 5.) Some studies performed in
vivo have described a beneficial role of the PAF antagonists [28]
or of calcium channel blockers [29] in the prevention of the
CsA-related nephrotoxicity. However, these results do not rule
out a possible inhibitory effect of VP on the CsA-induced
stimulation of PAF synthesis.
Two aspects of the present work require an additional dis-
cussion. It is possible that PAF is not the only mediator
involved in the reduction of cell surface induced by CsA. Other
mediators could also play a role before or after PAF production.
However, the total inhibition of CsA effects on mesangial cells
when they were incubated with BN 52021 or alprazolam sug-
gests that the increased synthesis of PAF is a limiting step in the
above described actions. The fact that VP only partially re-
versed the CsA-induced reduction of planar surface of mesan-
gial cells emphasizes the important role of the intracellular
calcium pools or other intracellular mediators in the response of
mesangial cells to different cellular stimuli [30]. Something
similar has been reported for the effect of angiotensin H in
mesangial cells [31].
The physiopathological importance of the present results
must be carefully analyzed. Reduction of planar surface of
mesangial cells has been widely accepted as mesangial contrac-
tion [15, 16, 32—34]. However, the present work lacks more
specific criteria of cellular contraction [35], and it could be
argued that the reduction of planar cell surface does not
necessarily mean cellular contraction. In order to analyze the
problem with a different approach, the effect of CsA on isolated
rat glomeruli was studied. If reduction of planar surface area of
cultured mesangial cells really represents cellular contraction, a
reduction of GCSA could be expected when glomeruli were
incubated under the same conditions as the cells. In fact, this
was the result obtained when glomeruli were incubated with
CsA 106 M, an action also inhibited by BN 52021 or VP.
Although this was only an indirect approach which did not take
into account a possible effect of CsA on epithelial or endothelial
glomerular cells, it must be considered a reasonable hypothesis
that must be confirmed by additional studies. Some link could
be established between these in vitro results and some in vivo
evidences. Recent results from Barros et al [8] have shown that
CsA could modify the glomerular filtration rate through an
effect on the ultrafiltration coefficient (Kf). A relationship
between mesangial contraction and reduction of ultrafiltration
surface, and consequently K1-, has been proposed as one of the
mechanisms responsible for the reduction of the GFR induced
by several hormones [15, 16]. Thus, we could suggest that
CsA-induced reduction of mesangial planar surface or GCSA
could be related to this decrease of K.
To confirm the hypothesis that PAF could mediate the
observed effects of CsA on cultured mesangial cells and isolated
glomeruli of rats, we measured the PAF synthesis by isolated
rat glomeruli in presence of CsA. To improve the method of
detection, PMSF was added to the incubation media in order to
inhibit the cellular acetyl-hydrolase activity [23]. Moreover, we
performed a previous extraction of the biological sample, being
able to completely separate PAF from thromboxane B2 or CsA.
In these conditions, we could observe a significant increase in
the PAF production after incubation with CsA. These results
strongly support the role of PAF in CsA-induced glomerular
and mesangial contraction. In addition, we tested the effect of
VP on the CsA-induced glomerular production of PAF. It did
not inhibit the stimulating effect of CsA, suggesting that it
partially blocked the contraction of mesangial cells induced by
CsA by blocking calcium movements through the cellular
membrane, not by preventing the increased synthesis of PAF
induced by CsA.
In summary, these results show that CsA reduces planar
surface area of cultured mesangial cells and GCSA of isolated
glomeruli, suggesting a possible contractile role for CsA at the
glomerular level. This fact could be related to the CsA-induced
decrease of K already reported and could mediate the acute
renal insufficiency attributed to CsA [3]. PAF production seems
to be a key intermediate step in the genesis of this action of
CsA. Although the present results point to calcium channel
blockers as an useful tool in preventing this effect of CsA, PAF
antagonists seem to be more effective; its pharmacological use
deserves further studies.
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